MRNA

Moderna Inc (MRNA) is the lead sponsor of 31 active clinical trials listed on ClinicalTrials.gov^[5], including 4 Phase 3^[1], 15 Phase 2^[2], 17 Phase 1^[3], 3 Phase 4^[4].

Trial NCT07117487^[6] evaluates mRNA-1345 in Respiratory Syncytial Virus with a target enrollment of 507 participants. Trial NCT06592794^[7] evaluates mRNA-1403 in Acute Gastroenteritis with a target enrollment of 37864 participants. Trial NCT06067230^[8] evaluates mRNA-1345 in Respiratory Syncytial Virus with a target enrollment of 1153 participants.

MRNA has 1 Form 4 insider filing recorded at the SEC in the past 30 days^[9].